{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:32:09Z","timestamp":1790857929897,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.pbb.2006.02.023","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T05:51:57Z","timestamp":1146808317000},"page":"403-409","source":"Crossref","is-referenced-by-count":29,"title":["Effects of terguride, ropinirole, and acetyl-l-carnitine on methamphetamine withdrawal in the rat"],"prefix":"10.1016","volume":"83","author":[{"given":"Michael E.","family":"Hoefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Voskanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Pulvirenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2006.02.023_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050812","article-title":"Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement","volume":"141","author":"Barr","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0091-3057(78)90214-9","article-title":"Cocaine reinforced progressive ratio performance in the rhesus monkey","volume":"9","author":"Bedford","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2006.02.023_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/03007995.2020.12102584","article-title":"Effects of acetyl-l-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors","volume":"19","author":"Bianchetti","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pbb.2006.02.023_bib4","first-page":"511","article-title":"Study of the efficacy and tolerability of l-acetylcarnitine therapy in the senile brain","volume":"24","author":"Bonavita","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.pbb.2006.02.023_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/070674370505000612","article-title":"Ropinirole in treatment-resistant depression: a 16-week pilot study","volume":"50","author":"Cassano","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pbb.2006.02.023_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02244434","article-title":"Behavioural profile of partial D2 dopamine receptor agonists. I. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy","volume":"105","author":"Clark","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0740-5472(03)00028-X","article-title":"Treatment of methamphetamine abuse: research findings and clinical directions","volume":"24","author":"Cretzmeyer","year":"2003","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.pbb.2006.02.023_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0924-977X(03)00146-9","article-title":"Buprenorphine in the treatment of opioid dependence","volume":"14","author":"Davids","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2006.02.023_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00126839-200203040-00001","article-title":"Acetyl-l-carnitine (levacecarnine) in the treatment of diabetic neuropathy: a long-term, randomised, double-blind, placebo-controlled study","volume":"3","author":"De Grandis","year":"2002","journal-title":"Drugs R D"},{"key":"10.1016\/j.pbb.2006.02.023_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1037\/0735-7044.106.2.386","article-title":"Low doses of haloperidol interfere with rat tongue extensions during licking: a quantitative analysis","volume":"106","author":"Fowler","year":"1992","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pbb.2006.02.023_bib11","first-page":"155","article-title":"Laevo-acetylcarnitine treatment of senile depression","volume":"27","author":"Fulgente","year":"1990","journal-title":"Clin Trials J"},{"key":"10.1016\/j.pbb.2006.02.023_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1385-299X(00)00056-8","article-title":"Animal models for the study of antidepressant activity","volume":"7","author":"Gambarana","year":"2001","journal-title":"Brain Res Brain Res Protoc"},{"key":"10.1016\/j.pbb.2006.02.023_bib13","first-page":"101","article-title":"Evaluation of the effects of l-acetylcarnitine on senile patients suffering from depression","volume":"16","author":"Garzya","year":"1990","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.pbb.2006.02.023_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(92)90154-V","article-title":"Acetyl-l-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study","volume":"218","author":"Harsing","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2006.02.023_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.134.3483.943","article-title":"Progressive ratio as a measure of reward strength","volume":"134","author":"Hodos","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.pbb.2006.02.023_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1037\/h0021818","article-title":"Motivational properties of long durations of rewarding brain stimulation","volume":"59","author":"Hodos","year":"1965","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.pbb.2006.02.023_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0165-6147(93)90129-8","article-title":"Partial agonists, full agonists, antagonists: dilemmas of definition","volume":"14","author":"Hoyer","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2006.02.023_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0091-3057(01)00472-5","article-title":"A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule","volume":"68","author":"Izzo","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2006.02.023_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pbb.2006.02.023_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03189938","article-title":"Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey","volume":"13","author":"Krause","year":"1988","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pbb.2006.02.023_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/BF02980169","article-title":"HPLC determination and pharmacokinetics of endogenous acetyl-l-carnitine (ALC) in human volunteers orally administered a single dose of ALC","volume":"27","author":"Kwon","year":"2004","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.pbb.2006.02.023_bib22","first-page":"17","article-title":"Postcocaine anhedonia: animals model of cocaine withdrawal","volume":"4","author":"Markou","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib23","first-page":"213","article-title":"Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal","volume":"7","author":"Markou","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.npp.1300078","article-title":"Effects of long-term acetyl-l-carnitine administration in rats\u2014II: protection against the disrupting effect of stress on the acquisition of appetitive behavior","volume":"28","author":"Masi","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opoid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00223989809599162","article-title":"Psychophysiological aspects of amphetamine\u2013methamphetamine abuse","volume":"132","author":"Murray","year":"1998","journal-title":"J Psychol"},{"key":"10.1016\/j.pbb.2006.02.023_bib27","first-page":"225","article-title":"Action of acetyl-l-carnitine in association with mianserine on depressed old people","volume":"3","author":"Nasca","year":"1989","journal-title":"New Trends Clin Neuropharmacol"},{"key":"10.1016\/j.pbb.2006.02.023_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/10550490490459915","article-title":"Methamphetamine abstinence syndrome: preliminary findings","volume":"13","author":"Newton","year":"2004","journal-title":"Am J Addict"},{"key":"10.1016\/j.pbb.2006.02.023_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0893-133X(01)00270-6","article-title":"Dopamine partial agonist reverses amphetamine withdrawal in rats","volume":"25","author":"Orsini","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF02244248","article-title":"Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats","volume":"103","author":"Paulson","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.mp.4000805","article-title":"Acetyl-l-carnitine physical\u2013chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression","volume":"5","author":"Pettegrew","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2006.02.023_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/npp.1993.23","article-title":"Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats","volume":"8","author":"Pulvirenti","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0165-6147(94)90158-9","article-title":"Dopamine receptor agonists, partial agonists, and psychostimulant addiction","volume":"15","author":"Pulvirenti","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2006.02.023_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0163-1047(90)91296-N","article-title":"Acetylcarnitine reduces the immobility of rats in a despair test (constrained swim)","volume":"54","author":"Pulvirenti","year":"1990","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.pbb.2006.02.023_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-3565(24)37716-X","article-title":"Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat","volume":"286","author":"Pulvirenti","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2006.02.023_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/004982599238696","article-title":"Disposition of ropinirole in animals and man","volume":"29","author":"Ramji","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pbb.2006.02.023_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pbb.2006.02.023_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0149-7634(01)00023-9","article-title":"D3 dopamine receptor, behavioral sensitization, and psychosis","volume":"25","author":"Richtand","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2006.02.023_bib39","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1523\/JNEUROSCI.17-07-02551.1997","article-title":"An escalating dose \u201cbinge\u201d model of amphetamine psychosis: behavioral and neurochemical characteristics","volume":"17","author":"Segal","year":"1977","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2006.02.023_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0091-3057(03)00188-6","article-title":"Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats","volume":"76","author":"Sibole","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2006.02.023_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00182999","article-title":"Effects of the partial dopamine receptor agonists SDZ 208-911, SDX 208\u2013912, and terguride on central monoamine receptors: a behavioral, biochemical, and electrophysiological study","volume":"344","author":"Svensson","year":"1991","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pbb.2006.02.023_bib42","first-page":"417","article-title":"l-acetylcarnitine in depressed elderly subjects: a cross-over study vs. placebo","volume":"13","author":"Tempesta","year":"1987","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.pbb.2006.02.023_bib43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0893-133X(02)00306-8","article-title":"Effects of long-term acetyl-l-carnitine administration in rats: I. Increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure","volume":"27","author":"Tolu","year":"2002","journal-title":"Neuropyshopharmacology"},{"key":"10.1016\/j.pbb.2006.02.023_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2006.02.023_bib45","first-page":"1","article-title":"Acetyl-l-carnitine in depressed geriatric patients","volume":"6","author":"Villardita","year":"1983","journal-title":"Eur Rev Med Pharm Sci"},{"key":"10.1016\/j.pbb.2006.02.023_bib46","series-title":"Neuroprotective agents: sixth international conference","first-page":"197","article-title":"Possible mechanism for the neuroprotective effects of l-carnitine on methamphetamine-evoked neurotoxicity","volume":"vol. 993","author":"Virmani","year":"2003"},{"key":"10.1016\/j.pbb.2006.02.023_bib47","first-page":"1","article-title":"The partial dopamine D(2)-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen","author":"Wacan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2006.02.023_bib48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/02791072.1978.10471538","article-title":"A clinical approach to diagnosis and treatment of amphetamine abuse","volume":"10","author":"Wesson","year":"1978","journal-title":"J Psychedelic Drugs"},{"key":"10.1016\/j.pbb.2006.02.023_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pbb.2006.02.023_bib50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"key":"10.1016\/j.pbb.2006.02.023_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF02245178","article-title":"Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds","volume":"117","author":"Wise","year":"1995","journal-title":"Psychopharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305706000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305706000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:34:57Z","timestamp":1736368497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305706000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0091305706000591"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2006.02.023","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}